Bioinformatics analysis demonstrated that EGCG affects NFκB1, Bcl-2, HIF-1α, MMP, etc., thereby reducing the risk of ovarian cancer (Xinqiang et al., 2017). This evidence concerns the gene BCL2 and ovarian cancer.